PORTSMOUTH, N.H. –June 27, 2007 -  Bottomline Technologies (NASDAQ: EPAY), a leading provider of collaborative payment and invoice automation solutions, today announced that Alpharma, a global specialty pharmaceutical company, has selected Bottomline’s document process automation platform to streamline the composition and delivery of transactional documents, including invoices, purchase orders and checks.

Bottomline’s award-winning platform allows organizations to automate and manage business processes that rely heavily on transactional documents. Through the electronic composition, routing, delivery and storage of transactional documents, organizations can operate and interact with customers and suppliers more efficiently and cost-effectively. Integrating with industry-leading Enterprise Resource Planning (ERP) systems, organizations such as Alpharma can quickly create and deliver these electronic documents across multiple communication channels such as fax, email, print or the Web.

“Comprehensive strategies for improving the efficiency of document creation and management are critical to highly regulated industries such as pharmaceuticals, and can quickly eliminate the cost and effort associated with creating, distributing, tracking and retrieving paper copies that impact profit,” said Rick Bell, Vice President and General Manager of Bottomline Technologies. “With the flexibility inherent in our platform, Alpharma will be able to introduce a greater degree of efficiency into key AP and AR transactional processes.”

About Alpharma, Inc.
Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals.  Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN® product. In addition, Alpharma is among the world’s leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

About Bottomline Technologies
Bottomline Technologies (NASDAQ: EPAY)provides collaborative payment and invoice automation solutions to corporations, financial institutions and banks around the world. The company’s solutions are used to streamline, automate and manage processes and transactions involving global payments, invoice approval, purchase-to-pay, collections, cash management and document process automation. Organisations trust these solutions to meet their needs for cost reduction, competitive differentiation and optimisation of working capital. Headquartered in the United States, Bottomline also maintains offices in Europe and Asia-Pacific. For more information, visit www.bottomline.com

Bottomline Technologies and the BT logo are trademarks of Bottomline Technologies, Inc. which may be registered in certain jurisdictions.  All other brand/product names are trademarks of their respective holders.

Cautionary Language
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are competition, market demand, technological change, strategic relationships, recent acquisitions, international operations and general economic conditions. For additional discussion of factors that could impact Bottomline Technologies' financial results, refer to the Company's Form 10-K filed September 2006, Form 10-Q filed May 2007 and any recently filed Form 8K's. Any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. We do not assume any obligation to update any forward-looking statements.

Contact
Billy Balfour
Bottomline Technologies   
bbalfour@bottomline.com
603-501-5219

Kathleen Makrakis
VP Investor Relations
Alpharma Inc. 
440 Route 22
Bridgewater, NJ 08807
investorrelations@alpharma.com
(908) 566-3800; (800) 200-9159